AXIM News Alert Axim Biotechnologies (AXIM) 10.0000 02/14/2015

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Innovative Solutions in Password Management Passwork, an industry leader in enterprise password management, has unveiled a groundbreaking solution promising to change the landscape of password breach detection forever. By employing advanced obfuscated deterministic Bloom filters, Passwork ensures organizations can check their passwords for breaches incredibly swiftly, all...

Delta's UFC 500 Ultra-Fast EV Charger certified for quality Delta has made headlines with its remarkable 500kW Ultra-Fast EV Charger, known as the UFC 500 Series, achieving German Eichrecht certification. This milestone marks a significant advancement in the realm of electric vehicle (EV) charging, showcasing Delta's commitment to innovation and excellence in power...

Savara Inc. Faces Class Action Lawsuit Over Regulatory Issues Recent developments in the biotech sector have captured the attention of investors as a class action lawsuit has been filed against Savara Inc. (NASDAQ: SVRA), a company dedicated to targeting rare respiratory diseases. This significant legal action, taken by Pomerantz LLP, has raised concerns among...

ICG Enterprise Trust Announces Share Buyback ICG Enterprise Trust plc (the “Company”) has made significant strides in its investment strategy by officially announcing a recent buyback transaction. On 14 April 2025, the Company acquired 15,000 of its own shares, which will now be held as treasury shares, at an average purchase price of 1157 pence each. Details of the...

Important Action Alert for Novo Nordisk Investors Bragar Eagel & Squire, P.C. is reaching out to all investors who experienced losses in Novo Nordisk (NVO). If you purchased or acquired Novo securities between May 7, 2025, and July 28, 2025, it's critical to be informed about your rights and potential legal options. Contact Information for Legal Assistance If your...